MA38621B1 - Compositions and methods for modulating the expression of hbv and ttr - Google Patents

Compositions and methods for modulating the expression of hbv and ttr

Info

Publication number
MA38621B1
MA38621B1 MA38621A MA38621A MA38621B1 MA 38621 B1 MA38621 B1 MA 38621B1 MA 38621 A MA38621 A MA 38621A MA 38621 A MA38621 A MA 38621A MA 38621 B1 MA38621 B1 MA 38621B1
Authority
MA
Morocco
Prior art keywords
ttr
hbv
modulating
expression
compositions
Prior art date
Application number
MA38621A
Other languages
French (fr)
Other versions
MA38621A1 (en
Inventor
Punit Seth
Thazha Prakash
Eric Swayze
Original Assignee
Ionis Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ionis Pharmaceuticals Inc filed Critical Ionis Pharmaceuticals Inc
Priority claimed from PCT/US2014/036463 external-priority patent/WO2014179627A2/en
Publication of MA38621A1 publication Critical patent/MA38621A1/en
Publication of MA38621B1 publication Critical patent/MA38621B1/en

Links

Abstract

L'invention concerne des composés oligomères à groupes conjugués. Dans certains modes de réalisation de l'invention, ces composés oligomères sont conjugués à la n-acétylgalactosamine.The invention relates to oligomeric compounds with conjugated groups. In certain embodiments of the invention, these oligomeric compounds are conjugated to n-acetylgalactosamine.

MA38621A 2013-05-01 2014-05-01 Compositions and methods for modulating the expression of hbv and ttr MA38621B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361818442P 2013-05-01 2013-05-01
PCT/US2014/036463 WO2014179627A2 (en) 2013-05-01 2014-05-01 Compositions and methods for modulating hbv and ttr expression

Publications (2)

Publication Number Publication Date
MA38621A1 MA38621A1 (en) 2018-06-29
MA38621B1 true MA38621B1 (en) 2019-04-30

Family

ID=63586942

Family Applications (2)

Application Number Title Priority Date Filing Date
MA46019A MA46019B1 (en) 2013-05-01 2014-05-01 Compositions and methods for modulating the expression of hbv and ttr
MA38621A MA38621B1 (en) 2013-05-01 2014-05-01 Compositions and methods for modulating the expression of hbv and ttr

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MA46019A MA46019B1 (en) 2013-05-01 2014-05-01 Compositions and methods for modulating the expression of hbv and ttr

Country Status (1)

Country Link
MA (2) MA46019B1 (en)

Also Published As

Publication number Publication date
MA38621A1 (en) 2018-06-29
MA46019B1 (en) 2022-08-31
MA46019A1 (en) 2020-12-31

Similar Documents

Publication Publication Date Title
DOP2021000095A (en) COMPOSITIONS AND METHODS TO MODULATE THE EXPRESSION OF TTR
CL2016001120A1 (en) Compounds derived from pyrrolo1,2-f1,2,4triazine, a pharmaceutical composition that comprises them and their use in the treatment of a syncytial virus infection intermediary compounds. pct
PH12015501720A1 (en) Modulators of methyl modifying enzymes, compositions and uses thereof
ECSP16005566A (en) SULFONAMIDES AS SODIUM CHANNEL MODULATORS
UY34645A (en) CONTROL OF PHYTOOPATHOGENIC MICROORGANISMS WITH PSEUDOMONAS SP. AND SUBSTANCES AND COMPOSITIONS DERIVED AS OF THE SAME
EA201690582A1 (en) MODULATORS OF COMPLEMENT FACTOR
UY35300A (en) FORMULATION OF COMBINATION OF TWO ANTIVIRAL COMPOUNDS
MA38982A1 (en) Novel octahydro-cyclobuta [1,2-c; 3,4-c '] dipyrrol-2-yl
EA201692204A1 (en) COMPOSITIONS AND METHODS OF MODULATING THE EXPRESSION OF COMPLEX B FACTOR
BR112015023387A2 (en) racecodotril lipid compositions
MX364069B (en) Flap modulators.
CL2018001493A1 (en) New phenyl derivatives
EA201600122A1 (en) NEW ISOINDOLINE OR ISOHINOLINE COMPOUNDS, METHOD FOR PRODUCING THEM AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
EA201070448A1 (en) NEW COMPOSITIONS ON THE BASIS OF TAXOIDS
IN2013DE03735A (en)
MA38294B1 (en) Refractory damping plate
CL2020000586A1 (en) Modulators of enac expression.
RS54412B1 (en) Honey composition with l-alanyl-l-glutamine
MA38621A1 (en) Compositions and methods for modulating the expression of hbv and ttr
CY1117740T1 (en) USE OF ODIPARCIL IN THE TREATMENT OF A MYCOPOLYSAKHARIDOSIS
UY34826A (en) SYNERGIC FUNGICIDE COMPOSITION.
MX2021007073A (en) Cosmetic composition.
EA201992461A3 (en) COMPOSITIONS AND METHODS FOR MODULATING HBV AND TTR EXPRESSION
MX2020013072A (en) Anti-pollution composition.
MA39071A1 (en) Substituted benzamides and their methods of use